NCT00000664View on ClinicalTrials.gov

Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Interleukin-2, Polyethylene Glycolated

DRUG

Zidovudine

Trial Locations (1)

94305

Stanford Univ School of Medicine, Stanford

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH